Skip to main content

Brandywine Trust Co

SEC CIK
0001123803
Latest filing
Aug 13, 2026

The latest 13F from Brandywine Trust Co covers Q2 2026 (filed Aug 13, 2026): 33 long positions worth $620.6M. The top 10 holdings make up 94.7% of the portfolio, and the largest is Vanguard Total World Stock ETF at 53.3%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
3
Est. +$3.48M
Added
5
Est. +$7.03M
Reduced
1
Est. −$1.11M
Sold out
1
Est. −$217.4K

Top 5 holdings

Share of this quarter's portfolio value

  1. Vanguard Total World Stock ETF922042742
    53.3%$330.5M
  2. SPYSPDR S&P 500 ETF Trust
    18.9%$117.3MHistory
  3. CPBCAMPBELL'S Co
    7.0%$43.5MHistory
  4. ABBVAbbVie Inc.
    4.1%$25.4MHistory
  5. BRK.ABerkshire Hathaway Inc
    2.7%$16.5MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. Vanguard Total World Stock ETF922042742
    +$5.36MAdded
  2. CRWDCrowdStrike Holdings, Inc.
    +$1.78MNewHistory
  3. Vanguard S&P 500 ETF922908363
    +$1.48MNew
  4. SPYSPDR S&P 500 ETF Trust
    +$1.21MAddedHistory
  5. Vanguard Ftse Developed Markets ETF921943858
    +$411.1KAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Vanguard Total World Stock ETF922042742
    +1.33 pp51.9% → 53.3%
  2. SPYSPDR S&P 500 ETF Trust
    +0.58 pp18.3% → 18.9%History
  3. CRWDCrowdStrike Holdings, Inc.
    +0.29 pp0.0% → 0.3%History
  4. Vanguard S&P 500 ETF922908363
    +0.24 pp0.0% → 0.2%
  5. Vanguard Ftse Developed Markets ETF921943858
    +0.05 pp1.7% → 1.8%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ABBVAbbVie Inc.
    −$1.11MReducedHistory
  2. GEHCGE HealthCare Technologies Inc.
    −$217.4KSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. ABBVAbbVie Inc.
    −0.06 pp4.1% → 4.1%History
  2. GEHCGE HealthCare Technologies Inc.
    −0.04 pp<0.1% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$620.6M
+$68.8M (+12.5%) vs. prior quarter
Positions
33
+2 vs. prior quarter
Top 10 concentration
94.7%
Top 10 as share of value
Turnover
0.2%
Q2 2026, one quarter
Average holding period
17.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $671.0M (Q3 2024)

Q1 2021: $318.7MQ2 2021: $316.1MQ3 2021: $286.9MQ4 2021: $297.6MQ1 2022: $305.0MQ2 2022: $295.4MQ3 2022: $277.6MQ4 2022: $327.6MQ1 2023: $371.1MQ2 2023: $454.4MQ3 2023: $414.4MQ4 2023: $497.2MQ1 2024: $589.6MQ2 2024: $602.2MQ3 2024: $671.0MQ4 2024: $634.1MQ1 2025: $645.0MQ2 2025: $654.6MQ3 2025: $657.4MQ4 2025: $570.4MQ1 2026: $551.8MQ2 2026: $620.6M
Q1 2021Q2 2026
13F filings of Brandywine Trust Co by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 13, 202633$620.6MVanguard Total World Stock ETFSPYCPBvs. Q1 2026SEC
Q1 2026May 14, 202631$551.8MVanguard Total World Stock ETFSPYCPBvs. Q4 2025SEC
Q4 2025Feb 13, 202632$570.4MVanguard Total World Stock ETFSPYCPBvs. Q3 2025SEC
Q3 2025Nov 14, 202533$657.4MVanguard Total World Stock ETFCPBSPYvs. Q2 2025SEC
Q2 2025Aug 14, 202535$654.6MVanguard Total World Stock ETFCPBSPYvs. Q1 2025SEC
Q1 2025May 15, 202535$645.0MVanguard Total World Stock ETFCPBSPYvs. Q4 2024SEC
Q4 2024Feb 14, 202532$634.1MVanguard Total World Stock ETFCPBSPYvs. Q3 2024SEC
Q3 2024Nov 14, 202433$671.0MVanguard Total World Stock ETFCPBSPYvs. Q2 2024SEC
Q2 2024Aug 14, 202431$602.2MCPBVanguard Total World Stock ETFSPYvs. Q1 2024SEC
Q1 2024May 15, 202431$589.6MCPBVanguard Total World Stock ETFSPYvs. Q4 2023SEC
Q4 2023Feb 14, 202430$497.2MCPBVanguard Total World Stock ETFSPYvs. Q3 2023SEC
Q3 2023Nov 14, 202326$414.4MCPBVanguard Total World Stock ETFSPYvs. Q2 2023SEC
Q2 2023Aug 14, 202329$454.4MCPBVanguard Total World Stock ETFSPYvs. Q1 2023SEC
Q1 2023May 15, 202325$371.1MCPBVanguard Total World Stock ETFSPYvs. Q4 2022SEC
Q4 2022Feb 14, 202324$327.6MCPBABBVSPYvs. Q3 2022SEC
Q3 2022Nov 14, 202222$277.6MCPBABBVSPYvs. Q2 2022SEC
Q2 2022Aug 15, 202224$295.4MCPBABBVSPYvs. Q1 2022SEC
Q1 2022May 13, 202229$305.0MCPBSPYABBVvs. Q4 2021SEC
Q4 2021Feb 10, 202229$297.6MCPBSPYABBVvs. Q3 2021SEC
Q3 2021Nov 15, 202133$286.9MCPBSPYABTvs. Q2 2021SEC
Q2 2021Aug 16, 202132$316.1MCPBSPYABBVvs. Q1 2021SEC
Q1 2021May 13, 202131$318.7MCPBSPYABT–SEC